• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肉瘤中CDK4基因与MDM2和GLI的共扩增。

Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

作者信息

Khatib Z A, Matsushime H, Valentine M, Shapiro D N, Sherr C J, Look A T

机构信息

Department of Experimental Oncology and Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.

出版信息

Cancer Res. 1993 Nov 15;53(22):5535-41.

PMID:8221695
Abstract

The 34-kilodalton cyclin-dependent kinase, p34cdk4, is a major catalytic subunit of mammalian D-type cyclins, which act during the G1 phase of the cell cycle to enforce the decision of cells to enter S phase. A murine complementary DNA clone was used to clone the cognate human CDK4 gene, which was localized to human chromosome 12, band q13, by fluorescence in situ hybridization. Because this chromosomal band contains the GLI and MDM2 genes, which are frequently amplified in human sarcomas, we analyzed CDK4 copy number and expression in a panel of sarcoma cell lines. An osteosarcoma cell line, OsACL, manifested a 25-fold increased copy number of CDK4, amplified concordantly with both GLI and MDM2, whereas a rhabdomyosarcoma cell line, SJRH30, was found to have an amplicon that included CDK4 and GLI but not MDM2. CDK4 mRNA and protein were overexpressed in both cell lines, and nucleotide sequencing analysis indicated that the gene had not sustained mutations. These observations provide the first evidence for amplification of a gene encoding a cell division cycle protein kinase, complement recent data indicating that genes encoding D-type cyclins are targets of chromosomal rearrangement and gene amplification in tumor cells, and suggest that CDK4 amplification might contribute to oncogenesis.

摘要

34千道尔顿的细胞周期蛋白依赖性激酶p34cdk4是哺乳动物D型细胞周期蛋白的主要催化亚基,在细胞周期的G1期发挥作用,促使细胞决定进入S期。利用小鼠互补DNA克隆来克隆同源的人类CDK4基因,通过荧光原位杂交将其定位到人类12号染色体q13带。由于该染色体带包含GLI和MDM2基因,这些基因在人类肉瘤中经常扩增,我们分析了一组肉瘤细胞系中CDK4的拷贝数和表达情况。骨肉瘤细胞系OsACL显示CDK4拷贝数增加了25倍,与GLI和MDM2一致扩增,而横纹肌肉瘤细胞系SJRH30被发现有一个包含CDK4和GLI但不包含MDM2的扩增子。CDK4 mRNA和蛋白在这两种细胞系中均过度表达,核苷酸测序分析表明该基因未发生突变。这些观察结果为编码细胞分裂周期蛋白激酶的基因扩增提供了首个证据,补充了最近的数据,即编码D型细胞周期蛋白的基因是肿瘤细胞中染色体重排和基因扩增的靶点,并表明CDK4扩增可能有助于肿瘤发生。

相似文献

1
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.人肉瘤中CDK4基因与MDM2和GLI的共扩增。
Cancer Res. 1993 Nov 15;53(22):5535-41.
2
Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.人类恶性胶质瘤中12q13 - q15扩增子的精细定位表明CDK4/SAS和MDM2是独立的扩增靶点。
Cancer Res. 1996 Nov 15;56(22):5141-5.
3
Amplification of the gli gene in childhood sarcomas.儿童肉瘤中gli基因的扩增。
Cancer Res. 1989 Oct 1;49(19):5407-13.
4
Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.人类肉瘤中12号染色体q13-14区域扩增单元的定位:一些扩增不包括MDM2。
Cell Growth Differ. 1993 Dec;4(12):1065-70.
5
Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.肉瘤中CDK4基因的扩增:肿瘤特异性及其与RB基因突变的关系。
Anticancer Res. 1998 Jul-Aug;18(4A):2317-21.
6
Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.在人类肉瘤中包含CDK4和MDM2的独立扩增区域。
Genes Chromosomes Cancer. 1996 Dec;17(4):254-9. doi: 10.1002/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO;2-2.
7
CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.细胞周期蛋白依赖性激酶4(CDK4)可能是肺癌中位于12号染色体长臂13.3区至14.1区的一个新扩增子中的靶基因。
Genes Chromosomes Cancer. 2005 Feb;42(2):193-9. doi: 10.1002/gcc.20122.
8
Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells.增强的蛋白质稳定性:在人肉瘤细胞中发现的D型细胞周期蛋白过度表达的新机制。
Oncogene. 1996 Jul 18;13(2):419-25.
9
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.p16-细胞周期蛋白D/Cdk4-pRb通路作为一个功能单元,在黑色素瘤发病机制中经常发生改变。
Cancer Res. 1996 Dec 1;56(23):5475-83.
10
Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers.人类癌症中12q13 - 15扩增的分子细胞遗传学特征及物理图谱分析
Genes Chromosomes Cancer. 1996 Dec;17(4):205-14. doi: 10.1002/(SICI)1098-2264(199612)17:4<205::AID-GCC2>3.0.CO;2-7.

引用本文的文献

1
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia.细胞周期蛋白依赖性激酶6(CDK6)激酶抑制揭示了BCR::ABL1+白血病中的代谢依赖性。
Cell Death Dis. 2025 Feb 18;16(1):107. doi: 10.1038/s41419-025-07434-1.
2
A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation.METTL1在tRNA氨基酰化和致癌转化中不依赖甲基转移酶的作用。
Mol Cell. 2025 Mar 6;85(5):948-961.e11. doi: 10.1016/j.molcel.2025.01.003. Epub 2025 Jan 31.
3
"GLI1 Subcellular Localization and Overexpression as Prognostic Factors for Disease-Free Survival in Colorectal Carcinoma".
“GLI1 亚细胞定位和过表达作为结直肠癌无病生存的预后因素”。
J Gastrointest Cancer. 2024 Sep;55(3):1359-1379. doi: 10.1007/s12029-024-01090-y. Epub 2024 Jul 17.
4
The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms.GLI1 和 p16 免疫组化在 GLI1 改变的间叶性肿瘤的分子前筛查中的价值。
Virchows Arch. 2024 May;484(5):765-775. doi: 10.1007/s00428-023-03687-3. Epub 2023 Nov 8.
5
Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses.RB缺失的综合多组学分析揭示了广泛的细胞编程和合成弱点。
Commun Biol. 2021 Aug 17;4(1):977. doi: 10.1038/s42003-021-02495-2.
6
Advances of Targeted Therapy for Hepatocellular Carcinoma.肝细胞癌靶向治疗的进展
Front Oncol. 2021 Jul 26;11:719896. doi: 10.3389/fonc.2021.719896. eCollection 2021.
7
GLI1: A Therapeutic Target for Cancer.GLI1:癌症的一个治疗靶点。
Front Oncol. 2021 May 25;11:673154. doi: 10.3389/fonc.2021.673154. eCollection 2021.
8
CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment.CDK4/6与丝裂原活化蛋白激酶的相互作用:癌症治疗的契机
Pharmaceuticals (Basel). 2020 Nov 24;13(12):418. doi: 10.3390/ph13120418.
9
Crosstalk of Hedgehog and mTORC1 Pathways.Hedgehog 和 mTORC1 通路的串扰。
Cells. 2020 Oct 18;9(10):2316. doi: 10.3390/cells9102316.
10
Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma.新型手性四氢萘并螺吲哚作为MDM2-CDK4双重抑制剂抗胶质母细胞瘤的合理药物设计、合成及生物学评价
Acta Pharm Sin B. 2020 Aug;10(8):1492-1510. doi: 10.1016/j.apsb.2019.12.013. Epub 2019 Dec 27.